Regulation of B Cell Identity and Lineage Progression
B 细胞身份和谱系进展的调节
基本信息
- 批准号:8420487
- 负责人:
- 金额:$ 36.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAntibodiesAutoimmune DiseasesB-Cell DevelopmentB-LymphocytesBone MarrowCD19 geneCell LineageCellsCore-Binding FactorDNA Sequence RearrangementDefectDevelopmentExhibitsGene ExpressionGene RearrangementGene TargetingGenesGenetic TranscriptionHematopoieticImmunoglobulin GenesImmunoglobulinsKnockout MiceLaboratoriesLightLight-Chain ImmunoglobulinsMaintenanceMalignant NeoplasmsMeasuresMediator of activation proteinMolecularMusMutateNatural Killer CellsNormal CellPhenotypeProcessProductionProteinsRegulationRelative (related person)RoleSignal TransductionStagingTestingTranscription Repressor/CorepressorTransgenesV(D)J Recombinationbasedosageinsightmutantpathogenpreventprogenitorpublic health relevanceresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): EBF1 is a crucial regulator of B lymphocyte lineage specification and commitment. In mice lacking EBF1 (encoded by the Ebf1 gene), B cell development is arrested and immunoglobulins (Ig) are not produced. Recently, we determined that mice with a single wild type Ebf1 allele (Ehet mice) exhibit defects in B cell development in the bone marrow. B cell development is further impaired in Ehet mice that also possess a single functional Runx1 (Rhet) allele. Runx1 encodes the Runt domain transcription factor Runx1 (CBF12/PEBP21), a functional partner of EBF1. In single Ehet and double (ERhet) haploinsufficient mice, we observed 1) substantially decreased numbers of CD19+ cells in the bone marrow, 2) delayed activation of pre-B cell markers, 3) reduced levels of Ig; light (L) chain rearrangements and 4) the loss of B cell identity, as evidenced by the mixing of B cell and NK cell phenotypes. The loss of B cell identity occurred in the presence of Pax5, a defined mediator of B cell commitment. We will address the central hypothesis that EBF1 is a primary regulator of B cell lineage specification and commitment. We propose that 1) the appropriate dosage of EBF1 is critical for establishing B cell identity and progression, and 2) this role of EBF1 is dependent on its functions as a transcriptional repressor, which is an undefined mechanism. We will continue our studies by identifying signaling defects in pro-B/pre-B cells that express reduced levels of EBF1. In the last aim, we will address whether EBF1 is required for the maintenance of B cell identity by utilizing new Ebf1 conditional knockout (Ecko) mice developed in our laboratory. Together, these studies will result in important new insights concerning functions of EBF1 in the regulation of B cell lineage specification, commitment and progression.
描述(由申请人提供):EBF 1是B淋巴细胞谱系特化和定型的关键调节因子。在缺乏EBF 1(由Ebf 1基因编码)的小鼠中,B细胞发育被阻止,并且不能产生免疫球蛋白(IG)。最近,我们确定了具有单个野生型Ebf 1等位基因的小鼠(Ehet小鼠)在骨髓中的B细胞发育中表现出缺陷。B细胞发育在也具有单一功能性Runx 1(Rhet)等位基因的Ehet小鼠中进一步受损。Runx 1编码Runt结构域转录因子Runx 1(CBF 12/PEBP 21),其是EBF 1的功能伴侣。在单Ehet和双(ERhet)单倍不足小鼠中,我们观察到1)骨髓中CD 19+细胞数量显著减少,2)前B细胞标志物活化延迟,3)IG水平降低;轻(L)链重排和4)B细胞身份丧失,如B细胞和NK细胞表型混合所证明。B细胞身份的丧失发生在Pax 5的存在下,Pax 5是B细胞定型的确定的介质。 我们将解决的核心假设,即EBF 1是一个主要的调节B细胞谱系的规范和承诺。我们提出:1)合适剂量的EBF 1对于建立B细胞身份和进展至关重要,2)EBF 1的这种作用依赖于其作为转录抑制因子的功能,这是一种未定义的机制。我们将继续我们的研究,通过确定前B/前B细胞中的信号缺陷,表达降低水平的EBF 1。在最后一个目标,我们将解决是否EBF 1是必需的B细胞的身份,通过利用新的Ebf 1条件性敲除(Ecko)小鼠在我们的实验室开发的维护。总之,这些研究将导致重要的新的见解有关功能的EBF 1的调节B细胞谱系的规范,承诺和进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James R. Hagman其他文献
James R. Hagman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James R. Hagman', 18)}}的其他基金
Regulation of V(D)J Recombination by Arginine Methylation
精氨酸甲基化对 V(D)J 重组的调节
- 批准号:
9087092 - 财政年份:2015
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of V(D)J Recombination by Arginine Methylation
精氨酸甲基化对 V(D)J 重组的调节
- 批准号:
8818975 - 财政年份:2015
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of B Cell Development and Function by Zfp521
Zfp521 对 B 细胞发育和功能的调节
- 批准号:
8401781 - 财政年份:2012
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of B Cell Development and Function by Zfp521
Zfp521 对 B 细胞发育和功能的调节
- 批准号:
9097469 - 财政年份:2012
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of B Cell Development and Function by Zfp521
Zfp521 对 B 细胞发育和功能的调节
- 批准号:
8503596 - 财政年份:2012
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of B Cell Development and Function by Zfp521
Zfp521 对 B 细胞发育和功能的调节
- 批准号:
8683097 - 财政年份:2012
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of B Cell Identity and Lineage Progression
B 细胞身份和谱系进展的调节
- 批准号:
8212274 - 财政年份:2010
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of B Cell Identity and Lineage Progression
B 细胞身份和谱系进展的调节
- 批准号:
8012293 - 财政年份:2010
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of B Cell Identity and Lineage Progression
B 细胞身份和谱系进展的调节
- 批准号:
7917958 - 财政年份:2010
- 资助金额:
$ 36.29万 - 项目类别:
Regulation of B Cell Identity and Lineage Progression
B 细胞身份和谱系进展的调节
- 批准号:
8605152 - 财政年份:2010
- 资助金额:
$ 36.29万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 36.29万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 36.29万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 36.29万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 36.29万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 36.29万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 36.29万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 36.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 36.29万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 36.29万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 36.29万 - 项目类别: